UOB-Kay Hian Holdings Limited Overview
| Item | Detail | Source |
|---|---|---|
| Legal name | UOB-Kay Hian Holdings Limited | AR2025 |
| Company registration no. | 200004464C | AR2025 |
| Former names (listed holdco) | None; predecessor listed entity was Kay Hian Holdings Ltd (delisted on the 2000 merger) | SGX corporate profile |
| Heritage / founding | Kay Hian & Co traces its history to the early 1900s as a commodities and securities dealer founded by Khoo Kay Hian; company incorporation in June 1970 per Google Finance profile | SGX corporate profile; Google Finance |
| Holdco incorporation | 24 May 2000, Republic of Singapore | SGX corporate profile |
| Listing | SGX Mainboard, listed 23 October 2000 | SGX corporate profile |
| Ticker(s) | SGX: U10; Reuters: U10.SI; Bloomberg: UOBK SP; secondary quote Frankfurt: 4LJ (aggregator) | SGX; DBS Initiation; TipRanks |
| ISIN | SG1J21887414 | SGXNet filings |
| CUSIP | Not applicable / not publicly disclosed (no US listing) | — |
| Registered office / HQ | 83 Clemenceau Avenue, #10-01 UE Square, Singapore 239920 | AR2025 |
| Fiscal year end | 31 December | AR2025 |
| Reporting frequency | Semi-annual (adopted from FY2020) | AR2025 CG Report |
| Auditor | Deloitte & Touche LLP, Singapore; partner-in-charge Chua How Kiat (appointed 27 April 2023) | AR2025 |
| FY2025 audit fees / non-audit fees | S$843,508 / S$113,753 | AR2025 CG Report |
| Share registrar | B.A.C.S. Private Limited | AR2025 |
| Company secretaries | Lee Wei Hsiung; Cheok Hui Yee | AR2025 |
| Principal bankers | DBS Bank, OCBC, Standard Chartered, HSBC, United Overseas Bank | AR2025 |
| Issued shares (30 Jun 2026) | 984,188,239 ordinary shares; zero treasury shares after sale of 10,000,000 treasury shares in 1H2026 | 1H2026 Results |
| Share price (latest retrieved close) | S$3.52 (9 October 2026) | StockAnalysis (delayed) |
| Market capitalisation (derived) | ~S$3.46 billion (S$3.52 × 984.19m shares) | derived |
| 52-week range (as of Aug 2026) | S$2.14 – S$4.44 | StockAnalysis |
| Controlling / substantial shareholders | United Overseas Bank Limited (~31.8%–32.2%); Wee Ee Chao via U.I.P. Holdings (~19.1%) and K.I.P. Inc (~17.0%) | DBS Initiation (S&P Cap IQ) |
| Website | uobkh.com (legacy: uobkayhian.com) | AR2025; SGX |
| Metric | FY2020 | FY2022 | FY2024 | FY2025 |
|---|---|---|---|---|
| Employees (approx., company-stated) | 3,053 | 3,134 | 3,123 | 2,000 |
Source: AR2020, AR2022, AR2024, AR2025 ("The Group employs approximately…"). The drop from ~3,123 to ~2,000 between AR2024 and AR2025 is not explained in the report; AR2025 simultaneously lists ~2,110 sales personnel across offices, which suggests the sales headcount includes remisiers/trading representatives who are not employees, and that the employee definition may have changed. Treat the FY2025 figure as a possible definitional break rather than a 36% workforce reduction.
UOB-Kay Hian is Singapore's only listed stockbroking house and, by its own description, the largest domestic broker in Singapore measured by registered trading representatives. It is a bank-affiliated but founder-run regional intermediary: United Overseas Bank holds roughly a third of the shares and provides much of the group's funding, while Chairman and Managing Director Wee Ee Chao — a member of the family that controls UOB — holds a larger combined stake through two investment vehicles. The group earns money from brokerage commissions across Asian and Western exchanges, interest on client margin and structured lending, and a growing wealth and structured-products franchise distributed through an advisory-led remisier network of roughly 2,100 sales staff across Singapore, Hong Kong, Malaysia, Thailand and Indonesia. Its earnings are highly geared to exchange turnover in Singapore and Hong Kong, both of which surged in 2025–2026, lifting the group to record results in FY2025 and 1H2026.
The company's own description (paraphrased from AR2025)
In AR2025 the group describes itself as a regional financial services group headquartered in Singapore, and claims to be the "largest domestic broker based on the number of registered trading representatives employed" in Singapore. Beyond brokerage across equities, bonds, CFDs, robo-advisory, leveraged FX, structured products, unit trusts and commodities, it offers wealth management services and uses its network of corporate contacts and distribution reach to provide corporate advisory and fund-raising services, including IPO execution, secondary placements and other corporate finance work. Its distribution footprint spans Singapore, Hong Kong, Thailand, Malaysia, Indonesia, London, New Jersey and Toronto, with a research office in Shanghai and an execution presence in the Philippines. The group emphasises demand from institutional and accredited-investor clients for research and multi-product, multi-market access.
The legal principal activities stated in the FY2025 and 1H2026 Results are: investment holding at the company level; and, at subsidiary level, stockbroking, futures broking, structured lending, investment trading, margin financing, investment holding, and nominee and research services.
Independent characterisation
UOB-Kay Hian is best understood as a leveraged play on Asian retail and high-net-worth trading activity with a growing balance-sheet lending business attached. Three economic engines drive it:
-
Agency commissions (the cyclical engine). Commission income was S$455.3m in FY2025 (59.6% of revenue). This is driven by exchange turnover in Singapore and Hong Kong (DBS estimates R-squared of 0.66 with SGX securities daily average value and 0.80 with HKEX turnover), and increasingly by structured-product distribution commissions, which DBS estimates now account for about 40% of revenue versus about 10% five years ago.
-
Interest income (the balance-sheet engine). Interest income of S$236.3m plus S$9.2m from FVTPL instruments in FY2025 (~32% of revenue) comes from three pools: interest on deposits of house cash and client float placed with banks (S$132.5m combined from related and non-related banks), interest charged to clients on margin and structured loans (S$96.5m), and other items. This engine is sensitive to policy rates: management estimates that rates 100bp lower in FY2025 would have reduced profit by about S$6.7m (DBS Initiation).
-
Fees and other revenue (the advisory engine). Facility, share-withdrawal and arrangement fees (S$15.6m), advisory fees (S$8.5m) and other operating revenue (S$21.5m) — together about 6% of revenue — capture structured-finance arrangement fees, corporate finance advisory and miscellaneous services.
Revenue model mix
| Revenue type (FY2025) | SGD Mn | % of revenue | Nature |
|---|---|---|---|
| Commission income | 455.3 | 59.6% | Transactional (service) |
| Trading income | 16.6 | 2.2% | Principal / market-making (small) |
| Interest income (amortised cost) | 236.3 | 31.0% | Balance-sheet / spread |
| Interest income (FVTPL instruments) | 9.2 | 1.2% | Balance-sheet |
| Dividend income | 0.5 | 0.1% | Investment |
| Facility, withdrawal & arrangement fees | 15.6 | 2.0% | Lending-related fees |
| Advisory fees | 8.5 | 1.1% | Corporate finance (service) |
| Other operating revenue | 21.5 | 2.8% | Miscellaneous |
| Total revenue | 763.5 | 100.0% | — |
Source: FY2025 Results, Note 17. Percentages derived: There is no product-sales, subscription or licensing revenue in the conventional sense. The closest recurring element is wealth-related income (structured products, discretionary portfolios, platform fees), which DBS estimates at roughly one-third of group revenue — a classification the company itself does not report.
Value-chain position
UOB-Kay Hian sits in the distribution and execution layer of the capital-markets value chain:
Upstream: exchanges and clearing houses (SGX, HKEX, Bursa Malaysia, SET, IDX, NYSE/NASDAQ, LSE, TSX), product manufacturers (structured-note issuers, fund houses) and funding banks (principally UOB Group).
Its layer: client acquisition through remisiers and digital platforms, execution, custody and nominee services (including CDP direct accounts in Singapore), margin and structured financing, research, and corporate finance origination.
Downstream: retail, mass-affluent, high-net-worth and institutional end-investors, and corporate issuers.
Equity derivatives arising from client transactions are hedged back-to-back with third-party issuers (FY2025 Results, Note 11), so the group carries limited directional market risk on structured products. Its main risks are credit risk on margin and structured loans, and turnover-driven earnings volatility.
Customer types
AR2025's sustainability section lists the client base as financial institutions, fund management companies, corporations, high-net-worth individuals and mass-market retail clients. DBS reports that more than three-quarters of revenue comes from the top 20% of customers by wealth, and that an estimated 50–60% of trading is self-executed electronically, with the rest executed through remisiers. No single customer contributes more than 10% of revenue (FY2025 Results, Note 24).
End-markets served
-
Cash equities brokerage: Singapore, Hong Kong (including Stock Connect), Malaysia, Thailand, Indonesia, US, UK and Canada
-
Derivatives: futures across 13 international markets; options (Hong Kong only)
-
Fixed income: global bond trading
-
Leveraged FX and CFDs
-
Wealth management: structured products, unit trusts, discretionary portfolios, external asset manager (EAM) platforms, private credit
-
Corporate finance: ECM underwriting and placement, M&A advisory, compliance advisory across SGX, HKEX, Bursa, SET and IDX
-
Structured finance: acquisition finance, holdco finance, bridge facilities, hybrids and illiquid-security financing for promoters, founders and substantial shareholders
Strategy
Stated strategy themes (paraphrased from AR2025 and 1H2026 Results)
The company does not publish a formal multi-year strategic plan or hold investor days. Its stated priorities, drawn from the Chairman's Statement (AR2025), the sustainability strategy and the 1H2026 outlook commentary, are:
-
Expand the wealth management franchise — the explicit focus in the 1H2026 outlook, building on structured products, discretionary and managed accounts, EAM partnerships and private credit.
-
Improve client experience — instant onboarding (UTRADE X), instant funding and withdrawals, and better research access.
-
Raise efficiency through automation and AI — straight-through processing, process automation (~4,000 man-hours saved in 2025) and internal AI chatbots for sales staff.
-
Expand service offerings — named in the Chairman's 2026 priorities.
-
Maintain cost discipline and prudent risk management — repeated in both FY2025 and 1H2026 commentary.
-
Sustainability pillars — corporate responsibility (compliance, governance, risk culture, community, environment), client centricity (fair dealing, data protection, client experience) and human capital (talent development, workplace well-being).
Strategic initiatives in the last 24 months
| Initiative | Timing | Description | Source |
|---|---|---|---|
| Wealth and structured-product pivot | From 2023, ongoing | Structured products rose to ~40% of revenue from ~10% five years earlier; 40–50 private bankers working with UOBKH | DBS Initiation |
| Private wealth leadership hire | 2,024 | Soh Ee Beng joins to lead private wealth management | DBS Initiation |
| Tikehau Capital private credit fund | Date not disclosed | US$50m Asia-Pacific private credit fund | DBS Initiation |
| inCadense managed-account platform | Date not disclosed | Enhanced managed-account platform | DBS Initiation |
| UTRADE X, Instant Deposit, Instant Withdrawal | FY2025 | Digital onboarding and funding upgrades | AR2025 |
| AI enablement | FY2025 | Internal chatbots summarising research for sales staff and remisiers | AR2025 |
| AML/CFT remediation | 2023–2025 | Enhanced due diligence and transaction monitoring; company states all MAS-required remediation completed | SGXNet statement 4 Jul 2025; AR2025 |
| Thailand privatisation | Nov 2025 – Apr 2026 | Voluntary delisting tender raises stake to 99.84% | SGXNet; Kaohoon |
| Board renewal | 2,025 | Two new independent directors; committee merger | AR2025 |
| Capital management | 1H2026 | Sale of 10m treasury shares for S$40.3m; renewal of share buyback mandate proposed at April 2026 AGM | 1H2026 Results; SGXNet 13 Apr 2026 |
| Climate disclosure | FY2025 | TCFD-aligned disclosures and NGFS scenario analysis | AR2025 |
Medium-term targets and guidance
Financial guidance: none. Each results filing states that no forecast or prospect statement has been previously disclosed to shareholders.
Dividend policy: pay out 50% of distributable profits (AR2025 CG Report).
Qualitative outlook (1H2026 Results, 7 Aug 2026): market conditions expected to remain supportive over the next 12 months, with volatility likely to persist due to uncertainty over the US rate path, the sustainability of AI-related investment, and geopolitics.
Qualitative outlook (FY2025 Results, 27 Feb 2026): cautiously optimistic; flags competitive pressure and digitalisation as possible sources of fee compression.
ESG targets: 10 short-term sustainability metrics, 8 achieved in FY2025.
Products & Services
The company does not report revenue by product. The catalogue below is compiled from AR2025 ("Our Products and Services"), AR2025 sustainability disclosures and the DBS Initiation.
Products
| Product | Description and capabilities | Target customer | Launch / latest update | Pricing model |
|---|---|---|---|---|
| Equities | Web, mobile and full-service offline trading across SGX, Bursa Malaysia, HKEX, HK–Shanghai/Shenzhen Stock Connect, SET, LSE, TSX, TSXV, NASDAQ, NYSE, NYSE ARCA and AMEX; supported by in-house research | Retail, HNW, institutional | Core since founding | Commission per trade (rates not in sources reviewed) |
| Exchange Traded Funds | Access to ETFs across major global markets with customisable watch-lists and screening tools | Retail, HNW | — | Commission per trade |
| Bonds | Global fixed-income trading, emerging to developed markets, with dedicated specialists | HNW, accredited, institutional | — | — |
| Contracts for Difference | Browser and mobile CFD trading on a Direct Market Access model in which each order participates in the underlying exchange, with no hidden spreads | Active traders, accredited investors | — | Commission plus financing (not disclosed) |
| Futures and Options | Futures across 13 international markets with 24-hour support; options available only for Hong Kong and only on desktop | Active traders, institutional | — | — |
| Leveraged FX | MT4 and Utrade Delta platforms, no dealing-desk intervention, segregated client funds, regular seminars | Active retail traders | — | — |
| Structured Products | Open-architecture suite sourced from multiple manufacturers, from yield enhancement to leveraged payoffs; includes coupon notes and structured notes; equity derivatives hedged back-to-back with third-party issuers | HNW, accredited investors | Expanded strongly from 2023 (DBS) | Distribution commission (not disclosed) |
| Robo Advisory | Digital portfolio manager using algorithms built with the group's research and investment staff, screening low-cost ETFs | Mass-affluent, digital retail | — | — |
| Unit Trusts | Wide fund selection with low sales commissions; straight-through-processing implemented for unit trust settlements in 2025 | Retail, mass-affluent | STP upgrade 2025 | Low sales commission |
| Private credit fund (with Tikehau Capital) | US$50m Asia-Pacific private credit fund | HNW, accredited | Date not disclosed in sources | — |
| inCadense managed-account platform | Enhanced managed-account (discretionary/advisory) platform | HNW | Date not disclosed in sources | — |
Services
| Service | Description | Target customer | Notes |
|---|---|---|---|
| Securities Dealing & Trading | Multi-asset execution across major Asian and developed exchanges for institutional and retail investors | All segments | The company positions itself as one of Asia's largest bank-backed brokers |
| Margin Trading | Leveraged trading across the portfolio with multi-currency financing and a broad list of qualifying securities | Retail, HNW | Client interest income was S$96.5m in FY2025 |
| Structured Finance | Bespoke lending and arranging for promoters, founders and substantial shareholders: acquisition finance, holdco finance, bridge facilities, hybrids, illiquid-security finance and other structured credit | Corporate insiders, HNW | Other loan receivables at amortised cost were S$1.31bn at 30 Jun 2026 (vs S$0.99bn at end-2025) |
| Wealth Management | Asia-centric solutions: asset allocation, discretionary portfolio management, asset-manager platforms and external investment products | HNW, accredited | DBS: 40–50 private bankers work with UOBKH; wealth ~one-third of revenue |
| Corporate Finance / Advisory | ECM underwriting and placement (primary and secondary), M&A, compliance advisory and financial advisory across SGX, HKEX, Bursa, SET and IDX | Issuers, corporates | Advisory fees were S$8.5m in FY2025 |
| Business Partnerships (B2B) | Execution, middle- and back-office solutions for robo-advisers, alternative (non-equity) exchanges and independent financial advisers | B2B partners | Includes custody and safety services for Endowus |
| External Asset Management | EAM solutions in partnership with Julius Baer, Bank of Singapore and UOB Private Bank | External asset managers, HNW | DBS Initiation |
| Independent Financial Adviser support | Intermediary support with product-agnostic open architecture | IFAs | DBS Initiation |
| Insurance introduction | Introduces clients to licensed insurance brokers | Wealth clients | DBS Initiation |
| Enhanced credit facilities | Partnerships with UBS and Goldman Sachs to provide enhanced credit to clients | HNW | DBS Initiation |
| Investor Education & Corporate Access | Coaching, seminars, technical-analysis curricula, networking events, roadshows and corporate access | Retail, institutional | — |
| Research | Equity and macro research; AR2025 lists 59 research staff (Singapore 9, Malaysia 18, Hong Kong 12, Thailand 10, Indonesia 5, Shanghai 5) | Institutional, accredited, retail | Research also shared with clients via platforms and LinkedIn |
| Nominee and custody services | Nominee services; in Singapore, margin accounts can be held in clients' own CDP accounts rather than custodian accounts (DBS identifies this as a differentiator versus low-cost brokers) | All | — |
Digital platforms and 2025 enhancements (AR2025)
| Platform / feature | Description | Launch year |
|---|---|---|
| UTRADE (web and mobile) | Core self-directed trading platform | — |
| UTRADE X | New account type enabling instant account opening and same-day trading | FY2025 |
| Instant Deposit | Immediate account funding on the UTRADE web platform via PayNow or bank transfer | FY2025 |
| Instant Withdrawal | Same-day withdrawals via FAST; MEPS/TT for larger or international transfers | FY2025 |
| Internal AI chatbots | Help sales staff and remisiers access and summarise in-house research | FY2025 |
| Process automation | Straight-through-processing for unit trust settlement and automation tools saving close to 4,000 man-hours | FY2025 |
Financial Narrative
Income statement
Sources and notes: FY2022–FY2025 from AR2025 Group Financial Highlights and FY2025 Results; FY2022 revenue excl. FX derived from FY2023 revenue of S$591.5m being +19.3% (media summary of FY2023 results). FY2021 revenue & FX, PBT and PATMI from S&P via TipRanks (FY2020 S&P figures reconcile exactly to AR2020, supporting basis consistency). FY2021 EPS derived as S$151.88m ÷ 851.02m weighted shares. FY2023 net revenue after commission expense and EBITDA from DBS Initiation; FY2021–FY2022 EBITDA from S&P via TipRanks; FY2024–FY2025 EBITDA derived as PBT + finance expense + depreciation. Diluted EPS equals basic EPS because there are no potential ordinary shares (FY2025 Results, Note 22). Discrepancy: one media summary of FY2023 results reported net profit of S$165.6m; AR2025 reports S$170.4m PATMI — the annual report figure is used.
Margins and growth
Derived from table 6.1. FY2021 growth rates use AR2020 FY2020 base (revenue & FX S$603.8m; PATMI S$159.4m).
Revenue CAGR (derived):
-
Revenue & FX gain, FY2021–FY2025: ~4.5% per year (depressed by the high FY2021 base from the pandemic-era trading boom)
-
Revenue excl. FX gain, FY2022–FY2025: ~15.5% per year (consistent with DBS's ">15% CAGR since 2022")
-
PATMI, FY2021–FY2025: ~12.0% per year
Cost structure (FY2024–FY2025)
Source: FY2025 Results; ratios derived: FY2024 other operating expenses included a S$9.6m Thailand goodwill impairment and S$15.7m of receivable allowances; neither recurred in FY2025 (allowance S$0.3m).
Balance sheet
Sources: FY2024–FY2025 from FY2025 Results; FY2022–FY2023 equity and NAV per share from AR2025; total assets, cash, total debt, net cash, working capital and FY2021 equity from S&P (via StockAnalysis); FY2021 NAV per share is S&P book value per share (S$2.02). Goodwill and intangibles combine S&P goodwill and other intangibles. All group borrowings are current, secured short-term bank loans; there is no long-term debt (FY2025 Results, Note 14).
30 June 2026 balance-sheet update (1H2026 Results):
The balance sheet expanded 41% in six months. Bank borrowings now exceed cash by about S$793m (derived), reversing the net-cash position at end-2025, as the group funded a surge in client receivables and unsettled trades.
Cash flow
Sources: FY2024–FY2025 from FY2025 Results; FY2021–FY2023 OCF, capex and FCF from S&P (via StockAnalysis); FY2023 dividends paid and debt change from DBS Initiation. No share buybacks were executed in the periods reviewed; 10,000,000 treasury shares held throughout were sold in 1H2026.
1H2026 cash flow: operating cash outflow of S$930.2m (driven by a S$2.20bn increase in receivables partly offset by a S$1.14bn increase in payables), funded by S$1.11bn of net new bank loans and S$40.3m from the treasury share sale; dividends of S$121.1m were paid entirely in cash (1H2026 Results).
Interpreting cash flow. For a broker, operating cash flow mainly reflects swings in client receivables, payables and unsettled trades at period-end rather than earnings quality. Negative operating cash flow in FY2024, FY2025 and 1H2026 reflects growth in margin and structured lending, not losses. Free cash flow is therefore a weak indicator here; the more relevant questions are funding cost and credit quality.
Ratios
Sources: ROE FY2022–FY2025 from AR2025; FY2021 derived. ROA, ROIC, current ratio, D/E and asset turnover from S&P (via StockAnalysis). Net debt/EBITDA and interest coverage derived (FY2021–FY2023 finance expense implied from S&P EBITDA and DBS net interest). Payout ratios from DBS Initiation. The cash conversion cycle is not meaningful for a securities broker and is not reported.
Interim performance (1H2025 vs 1H2026)
Source: 1H2026 Results. The interim dividend was nil in both periods (the company pays one final dividend per year).
Trend commentary
FY2021 → FY2022 (downturn). Revenue fell about 22% as the 2020–2021 retail trading boom faded, Chinese property stress and recession fears hit Hong Kong and Singapore turnover, and PATMI fell 33% to S$101.9m — the trough of the period. The dividend was cut to 6.0 cents.
FY2022 → FY2024 (recovery and rate windfall). Rising policy rates lifted interest income on house cash and client float — DBS data show deposit interest from non-related banks jumping 221% in FY2023 — while commission income stabilised. PATMI rose 67% in FY2023 and 32% in FY2024 to a then-record S$224.2m, despite the FY2024 Thailand goodwill write-off.
FY2024 → FY2025 (turnover-led growth, rate drag). Commission and trading income rose 28.0% on structured-product commissions and higher turnover in Singapore, Hong Kong and the US, while interest income slipped 2.7% as rates fell. Higher staff and commission costs absorbed much of the revenue gain, so PATMI rose only 6.8% — clear evidence of operating de-leverage from the variable-pay model.
1H2026 (inflection). Revenue grew 41.8% and PATMI 66.0%, as SGX turnover surged under the MAS Equity Market Development Programme and Hong Kong IPO and Stock Connect activity stayed strong. Two early warnings sit under the headline: finance expense doubled on the larger loan book, and the receivable impairment charge rose to S$6.1m from S$0.4m.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment metric | FY2024 | FY2025 |
|---|---|---|
Singapore revenue (SGD Mn) | 382.3 | 429.6 |
Hong Kong revenue (SGD Mn) | 183.0 | 239.0 |
Thailand revenue (SGD Mn) | 38.7 | 35.1 |
Malaysia revenue (SGD Mn) | 70.4 | 71.7 |
Others revenue (SGD Mn) | 9.7 | 11.6 |
Elimination (SGD Mn) | -13.8 | -23.4 |
Group revenue (SGD Mn) | 670.3 | 763.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment result (pre-tax profit) | FY2024 | FY2025 |
|---|---|---|
Singapore PBT (SGD Mn) | 163.9 | 157.5 |
Hong Kong PBT (SGD Mn) | 74.7 | 90.2 |
Thailand PBT (SGD Mn) | -5.8 | 0.5 |
Malaysia PBT (SGD Mn) | 24.4 | 20.5 |
Others PBT (SGD Mn) | -2.1 | 2.5 |
Elimination (SGD Mn) | -0.3 | -0.3 |
Group PBT (SGD Mn) | 254.8 | 270.9 |
Segment Revenue
| Segment | FY2025 PBT margin | FY2024 PBT margin | FY2025 revenue growth | FY2025 PBT growth | FY2025 share of segment revenue (pre-elim.) |
|---|---|---|---|---|---|
Singapore | 36.7% | 42.9% | +12.4% | -3.9% | 54.6% |
Hong Kong | 37.7% | 40.8% | +30.6% | +20.8% | 30.4% |
Thailand | 1.4% | -15.0% | -9.4% | n.m. (loss to profit) | 4.5% |
Malaysia | 28.6% | 34.7% | +1.8% | -15.9% | 9.1% |
Others | 21.9% | -21.9% | +19.3% | n.m. (loss to profit) | 1.5% |
Results by Segment (1H2025–1H2026)
| Segment metric | 1H2025 | 1H2026 |
|---|---|---|
Singapore revenue (SGD Mn) | 188.0 | 289.9 |
Hong Kong revenue (SGD Mn) | 108.4 | 138.8 |
Thailand revenue (SGD Mn) | 16.1 | 23.0 |
Malaysia revenue (SGD Mn) | 31.9 | 38.4 |
Others revenue (SGD Mn) | 4.0 | 5.4 |
Singapore PBT (SGD Mn) | 55.5 | 123.8 |
Hong Kong PBT (SGD Mn) | 43.3 | 50.1 |
Thailand PBT (SGD Mn) | 0.2 | 4.4 |
Malaysia PBT (SGD Mn) | 9.2 | 13.0 |
Others PBT (SGD Mn) | 0.6 | -7.1 |
Group PBT (SGD Mn) | 110.3 | 189.3 |
Revenue Lines
| Revenue line | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Commission income (SGD Mn) | 286 | 356.3 | 455.3 |
Trading income (SGD Mn) | 7 | 12.4 | 16.6 |
Interest income, amortised cost (SGD Mn) | 244 | 242.8 | 236.3 |
Interest income, FVTPL (SGD Mn) | 19 | 10.5 | 9.2 |
Facility, withdrawal & arrangement fees (SGD Mn) | 9 | 14.3 | 15.6 |
Advisory fees (SGD Mn) | 8 | 8.2 | 8.5 |
Other operating revenue incl. dividends (SGD Mn) | 19 | 25.7 | 22.0 |
Total revenue (SGD Mn) | 592 | 670.3 | 763.5 |
Group Entities
| Entity | Country | Role | Auditor | Ownership |
|---|---|---|---|---|
UOB Kay Hian Private Limited | Singapore | Principal Singapore broker; MAS-licensed capital markets services licensee | Deloitte & Touche LLP | Not specified in sources (presumed wholly owned) |
UOB Kay Hian (Hong Kong) Limited | Hong Kong | Hong Kong brokerage | Deloitte Touche Tohmatsu | Not specified in sources |
UOB Kay Hian (M) Sdn. Bhd. | Malaysia | Malaysian brokerage | Deloitte PLT | Not specified in sources |
UOB Kay Hian Securities (Thailand) PCL | Thailand | Thai brokerage (SET seat 26); delisted 25 Apr 2026 | Deloitte Touche Tohmatsu Jaiyos | 99.84% (direct + indirect) after Apr 2026 tender |
PT Kay Hian Sekuritas (as listed in AR2025 auditor table) | Indonesia | Indonesian brokerage | PKF member firm (Paul Hidajat, Arsono, Retno, Palilingan & Rekan) | Not specified in sources |
UOB Kay Hian Securities (Philippines), Inc | Philippines | Execution presence | Reyes Tacandong & Co. | Not specified in sources |
UOB Kay Hian (BVI) Limited | BVI | Intermediate holding (holds part of the Thai stake) | Not specified | Wholly owned |
London, New Jersey, Toronto entities; Shanghai research office | UK / US / Canada / China | Sales and research | Not specified | — |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue excl. FX gain (SGD Mn) | — | 495.8 | 591.5 | 670.3 | 763.5 |
Revenue and FX gain (SGD Mn) | 644.2 | 503.5 | 597.1 | 698.2 | 767.4 |
Net revenue after commission expense (SGD Mn) | — | — | 520 | 583.3 | 648.7 |
Profit before tax / profit from operations (SGD Mn) | 173.6 | 121.4 | 190.2 | 254.8 | 270.9 |
EBITDA, derived (SGD Mn) | 230.1 | 178.2 | 257 | 305.0 | 327.0 |
Profit after tax (SGD Mn) | — | 102.9 | 170.8 | 223.7 | 239.4 |
Profit after tax and minority interests (SGD Mn) | 151.9 | 101.9 | 170.4 | 224.2 | 239.4 |
Basic EPS (S cents) | 17.85 | 11.63 | 19.08 | 24.42 | 25.06 |
Diluted EPS (S cents) | 17.85 | 11.63 | 19.08 | 24.42 | 25.06 |
Dividend per share (S cents) | 8.8 | 6.0 | 9.2 | 11.9 | 12.3 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PBT margin on revenue & FX (%) | 26.9 | 24.1 | 31.9 | 36.5 | 35.3 |
EBITDA margin on revenue & FX (%) | 35.7 | 35.4 | 43.0 | 43.7 | 42.6 |
Net margin, PATMI on revenue & FX (%) | 23.6 | 20.2 | 28.5 | 32.1 | 31.2 |
Revenue & FX growth (%) | 6.7 | -21.8 | 18.6 | 16.9 | 9.9 |
PATMI growth (%) | -4.7 | -32.9 | 67.2 | 31.6 | 6.8 |
Cost line
| Cost line | FY2024 | FY2025 |
|---|---|---|
Commission expense (SGD Mn) | 87.0 | 114.7 |
Staff costs (SGD Mn) | 212.3 | 249.6 |
Finance expense (SGD Mn) | 38.6 | 40.6 |
Other operating expenses (SGD Mn) | 105.6 | 91.7 |
Total expenses (SGD Mn) | 443.5 | 496.6 |
Cost-to-income, total expenses / revenue & FX (%) | 63.5 | 64.7 |
Staff costs / revenue (%) | 31.7 | 32.7 |
Effective tax rate (%) | 12.2 | 11.6 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (SGD Mn) | 4,521 | 4,323 | 3,994 | 4,594 | 5,679 |
Cash and cash equivalents (SGD Mn) | 547.6 | 1,244 | 1,036 | 918.3 | 1,290.5 |
Bank borrowings, short-term (SGD Mn) | — | — | — | 597.0 | 1,118.2 |
Debts issued, notes (SGD Mn) | — | — | — | 224.6 | 142.6 |
Total debt incl. notes and leases, S&P basis (SGD Mn) | 1,511 | 1,434 | 916.9 | 946.8 | 1,591 |
Long-term debt (SGD Mn) | 0 | 0 | 0 | 0 | 0 |
Net cash, S&P basis, positive = net cash (SGD Mn) | -476.2 | 121.9 | 494.8 | 386.6 | 403.6 |
Shareholders' equity excl. NCI (SGD Mn) | 1,743 | 1,780.3 | 1,893.2 | 2,117.0 | 2,269.8 |
Goodwill and intangibles (SGD Mn) | 13.7 | 12.5 | 11.7 | 2.0 | 2.1 |
Working capital, S&P basis (SGD Mn) | 1,441 | 1,578 | 1,751 | 1,941 | 2,143 |
NAV per share (S cents) | 202 | 201.04 | 210.35 | 226.40 | 232.99 |
Client trust/segregated balances, off-balance sheet (SGD Mn) | — | — | — | 4,746.6 | 5,994.2 |
Balance Sheet and Per-Share Data (31 Dec 2025–30 Jun 2026)
| Item | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Total assets (SGD Mn) | 5,679.0 | 7,982.4 |
Cash and cash equivalents (SGD Mn) | 1,290.5 | 1,431.0 |
Outstanding contracts receivable (SGD Mn) | 835.5 | 1,941.2 |
Trade and other receivables, current (SGD Mn) | 2,574.9 | 3,614.2 |
Bank borrowings (SGD Mn) | 1,118.2 | 2,224.3 |
of which from UOB Group (related parties) (SGD Mn) | 826.0 | 1,361.8 |
Debts issued (SGD Mn) | 142.6 | 137.1 |
Equity attributable to owners (SGD Mn) | 2,269.8 | 2,347.3 |
NAV per share (S cents) | 232.99 | 238.50 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (SGD Mn) | 68.8 | 798.4 | 384.1 | -91.9 | -67.4 |
Capital expenditure (SGD Mn) | 5.1 | 2.7 | 4.2 | 4.8 | 14.7 |
Free cash flow (SGD Mn) | 63.7 | 795.7 | 379.9 | -96.7 | -82.1 |
Dividends paid in cash (SGD Mn) | — | — | 26 | 39.8 | 50.4 |
Dividends settled in scrip shares (SGD Mn) | — | — | — | 43.0 | 60.8 |
Share buybacks (SGD Mn) | 0 | 0 | 0 | 0 | 0 |
Net drawdown / (repayment) of bank loans (SGD Mn) | — | — | -541 | -15.5 | 533.9 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, PATMI / closing equity (%) | 8.7 | 5.78 | 9.28 | 11.18 | 10.91 |
ROA, S&P average-assets basis (%) | 3.36 | 2.33 | 4.11 | 5.21 | 4.66 |
ROIC, S&P basis (%) | 4.28 | 2.97 | 5.50 | 7.02 | 6.78 |
Current ratio, S&P (x) | 1.53 | 1.64 | 1.85 | 1.81 | 1.64 |
Debt / equity, S&P (x) | 0.86 | 0.80 | 0.48 | 0.44 | 0.70 |
Net debt / EBITDA (x, negative = net cash) | 2.07 | -0.68 | -1.93 | -1.27 | -1.23 |
Interest coverage, (PBT + finance exp.) / finance exp. (x) | 5.6 | 4.1 | 4.6 | 7.6 | 7.7 |
Asset turnover, S&P (x) | 0.13 | 0.10 | 0.13 | 0.15 | 0.14 |
Dividend payout, company/DBS (%) | 49.4 | 51.5 | 48.5 | 49.7 | 50.0 |
Income Statement and Per-Share Data (1H2025–1H2026)
| Metric | 1H2025 | 1H2026 |
|---|---|---|
Revenue (SGD Mn) | 339.1 | 481.1 |
Commission and trading income (SGD Mn) | 206.7 | 313.2 |
Interest income (SGD Mn) | 114.4 | 137.3 |
Other operating income (SGD Mn) | 18.1 | 30.6 |
Net FX gain / (loss) (SGD Mn) | -16.4 | 9.6 |
Commission expense (SGD Mn) | 51.5 | 68.8 |
Staff costs (SGD Mn) | 101.6 | 142.9 |
Finance expense (SGD Mn) | 18.0 | 37.3 |
Other operating expenses (SGD Mn) | 41.4 | 52.3 |
Profit before tax (SGD Mn) | 110.3 | 189.3 |
PATMI (SGD Mn) | 99.2 | 164.7 |
EPS (S cents) | 10.60 | 16.86 |
FY2025 Component Details
| FY2025 component | Singapore | Hong Kong | Thailand | Malaysia | Others |
|---|---|---|---|---|---|
External sales (SGD Mn) | 260.0 | 160.0 | 28.0 | 61.2 | 8.7 |
Interest income (SGD Mn) | 149.6 | 78.3 | 6.6 | 9.2 | 1.8 |
Interest share of segment revenue, derived (%) | 34.8 | 32.8 | 19.0 | 12.9 | 15.3 |
Revenue by Region
| Region (S&P basis) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Singapore revenue (SGD Mn) | 302.7 | 240.9 | 307.0 | 347.7 | 392.3 |
Hong Kong revenue (SGD Mn) | 152.8 | 115.7 | 145.1 | 179.9 | 236.2 |
Thailand revenue (SGD Mn) | 68.8 | 53.4 | 43.9 | 38.1 | 34.7 |
Malaysia revenue (SGD Mn) | 67.4 | 49.5 | 50.4 | 69.9 | 71.3 |
Others revenue (SGD Mn) | 13.8 | 14.0 | 12.0 | 9.4 | 11.4 |
Revenue by Region (FY2024–FY2025)
| Region (company basis) | FY2024 | FY2025 |
|---|---|---|
Singapore revenue (SGD Mn) | 382.3 | 429.6 |
Hong Kong revenue (SGD Mn) | 183.0 | 239.0 |
Thailand revenue (SGD Mn) | 38.7 | 35.1 |
Malaysia revenue (SGD Mn) | 70.4 | 71.7 |
Others revenue (SGD Mn) | 9.7 | 11.6 |
Revenue by Region (%)
| Region (%) | FY2025 growth (company basis) | FY2021–FY2025 CAGR (S&P basis, derived) |
|---|---|---|
Singapore | +12.4% | +6.7% |
Hong Kong | +30.6% | +11.5% |
Thailand | -9.4% | -15.7% |
Malaysia | +1.8% | +1.4% |
Others | +19.3% | -4.7% |
Share Price
| Price datapoint | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
Approx. year-end share price, derived (SGD) | 1.42 | 1.60 | 1.40 | 1.33 | 1.68 | 2.56 |
Share Price & Returns
| Horizon | Approx. return to 9 Oct 2026 (S$3.52) | Basis |
|---|---|---|
1 year | ~+38% | vs ~S$2.55 in early Oct 2025 (insider-trade prices) |
3 years | ~+160% | vs ~S$1.35 in Oct 2023 (approximate) |
5 years | ~+120–135% | vs ~S$1.5–1.6 in Oct 2021 (approximate) |
Year to date 2026 | ~+38% | vs ~S$2.56 at end-2025 |
From 52-week high (S$4.44) | ~-21% | StockAnalysis |
Valuation Multiples
| Multiple | UOB-Kay Hian | Basis |
|---|---|---|
P/E, trailing 12 months | ~11.3x | TTM PATMI S$304.9m (derived: FY2025 239.4 − 1H2025 99.2 + 1H2026 164.7); TTM EPS ~31.2 cents |
P/E, FY2025 | ~14.0x | FY2025 EPS 25.06 cents |
P/E, FY2026F (DBS) | ~12.9x | DBS FY2026F EPS 27.3 cents |
P/B | ~1.48x | NAV per share 238.5 cents (30 Jun 2026) |
EV/EBITDA, TTM | ~10.3x | EV ≈ S$4.42bn (market cap + S&P net debt S$956m); TTM EBITDA ≈ S$430m (derived) |
EV/Sales, TTM | ~4.9x | TTM revenue ≈ S$905.5m (derived) |
Dividend yield, trailing | ~3.5% | 12.3 cents |
Dividend yield, FY2026F (DBS) | ~3.9% | 13.7 cents |
Valuation Multiples (x) and Market Valuation
| Valuation (S&P, year-end) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
P/E (x) | 9.04 | 12.00 | 7.08 | 7.01 | 10.46 |
P/B (x) | 0.78 | 0.68 | 0.63 | 0.74 | 1.10 |
Market capitalisation (SGD Mn) | 1,373 | 1,222 | 1,206 | 1,571 | 2,504 |
Analyst Ratings & Targets
| Broker | Date | Rating | Target price (SGD) | Basis |
|---|---|---|---|---|
DBS Group Research | 3 Jul 2026 | BUY | 4.80 | ~15x FY2027F P/E |
Macquarie | 16 Jan 2026 | Outperform | 3.12 (bull case 3.91) | — |
Consensus (StockAnalysis, 3 analysts) | Aug–Oct 2026 | Strong Buy | 4.80 average | Aggregator |
Income Statement and Per-Share Data (FY2023–FY2027F)
| DBS forecast | FY2023 | FY2024 | FY2025 | FY2026F | FY2027F |
|---|---|---|---|---|---|
Revenue (SGD Mn) | 592 | 670 | 763 | 880 | 995 |
Net profit (SGD Mn) | 171 | 224 | 239 | 275 | 306 |
EPS (S cents) | 19.0 | 23.9 | 24.6 | 27.3 | 29.5 |
DPS (S cents) | 9.2 | 11.9 | 12.3 | 13.7 | 14.7 |
ROAE (%) | 9.3 | 11.2 | 10.9 | 11.5 | 11.8 |
Dividend metric
| Dividend metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
DPS (S cents) | 9.5 | 8.8 | 6.0 | 9.2 | 11.9 | 12.3 |
Payout ratio (%) | 49.5 | 49.4 | 51.5 | 48.5 | 49.7 | 50.0 |
EPS (S cents) | 19.21 | 17.85 | 11.63 | 19.08 | 24.42 | 25.06 |
Capital Markets
| Item | Status |
|---|---|
Moody's / S&P / Fitch issuer ratings | None; the company is unrated (no public ratings identified) |
Bond issuance | No public bonds; "debts issued" of S$137.1m are client-linked notes designated at FVTPL and matched by loan receivables of S$137.1m (1H2026 Results, Notes 5 and 15) |
Maturity profile | 100% current: short-term bank loans of S$2.22bn (S$1.36bn from UOB-related parties, S$0.86bn from non-related banks); no long-term debt |
Security | Group bank borrowings of S$1.83bn secured by a fixed charge over immovable assets and a floating charge over all assets |
Lease liabilities | S$25.7m (S$20.4m current) |
Analyst Conclusions
Management guidance
No quantitative guidance is given. The company's 7 August 2026 commentary expects supportive conditions over the next 12 months, citing MAS market-development initiatives in Singapore and IPO recovery and Stock Connect volumes in Hong Kong, while warning of volatility from the US rate outlook, AI-investment sustainability and geopolitics. Priorities: wealth franchise expansion, cost discipline and prudent risk management.
Consensus expectations
The only detailed published forecasts retrieved are DBS's: revenue +15.2% to S$880m and net profit +14.8% to S$275m in FY2026F; +13.2% and +11.5% in FY2027F. The 1H2026 run-rate (revenue +41.8%, PATMI +66.0%) is running well ahead of these estimates.
Bull case
-
Structural, not just cyclical, Singapore turnover recovery. With SGX turnover up about 46% year-on-year and most Equity Market Development Programme capital still to deploy, plus 27 IPOs in the pipeline, Singapore (55% of revenue, where PBT more than doubled in 1H2026) could sustain elevated earnings into 2027.
-
Mix shift toward higher-quality income. Wealth is about one-third of revenue and structured products about 40%; facility fees rose 179% in 1H2026. Recurring, less turnover-sensitive income should support a higher multiple, as DBS argues.
-
Earnings momentum ahead of estimates at a reasonable valuation. TTM P/E of about 11.3x and P/B of about 1.5x for a ~11–12% ROE business whose 1H2026 profit already covers about 60% of DBS's full-year forecast; the 20% share-price pullback from the high widens the gap.
Bear case
-
Peak-cycle earnings. UOBKH's earnings have repeatedly mean-reverted (FY2022 PATMI -33%). The 1H2026 surge coincides with record Hong Kong and Singapore activity and an AI-led rally that management itself flags as a risk.
-
Balance-sheet risk has risen quietly. In six months, bank borrowings doubled to S$2.22bn, the group flipped to net bank debt of about S$0.8bn, receivables jumped S$1.1bn, finance expense doubled and impairment charges rose 16-fold. A market drawdown could turn margin and structured loans into credit losses.
-
Structural share loss to digital platforms and governance overhang. Futu, Tiger and iFAST are growing several times faster; UOBKH's fee pool on self-directed flow is exposed. A combined Chairman/MD, two MAS penalties, sizable director selling and a 32% free float limit institutional appetite and multiple expansion.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| SGX and HKEX monthly turnover statistics | Monthly | Whether SGX turnover growth stays above +20% year-on-year |
| FY2026 results and dividend | Late Feb 2027 | PATMI vs ~S$275m DBS estimate; DPS vs 13.7 cents; scrip vs cash |
| Credit quality | Feb 2027 / Aug 2027 | Receivable allowances, loan book growth, finance expense |
| Equity Market Development Programme deployment and SGX IPO pipeline | Ongoing | New listings, small/mid-cap liquidity |
| Fed and MAS rate path | Ongoing | Interest income sensitivity (~S$6.7m per 100bp) |
| Thai post-delisting restructuring | 2026–2027 | Thai segment profitability |
| AGM 2027, board renewal, succession signals | Apr 2027 | Lead ID appointment, succession planning, gender diversity |
| Regulatory actions (MAS, SFC) | Ongoing | Any further AML/conduct penalties |
| Use of buyback mandate | Ongoing | Capital return beyond dividends |
| Insider dealings | Ongoing | Further director or controlling-shareholder disposals |
Concluding analyst verdict
UOB-Kay Hian enters late 2026 in the strongest earnings position in its 26-year listed history. FY2025 delivered record revenue of S$763.5m and profit of S$239.4m. 1H2026 then added a record S$164.7m of half-year profit, as Singapore's state-backed equity revival and Hong Kong's AI-driven rally flowed directly through a franchise that is, by its own measure, Singapore's largest domestic broker. The business is more diversified than in past cycles: interest income and a fast-growing structured-product and wealth book now sit alongside commissions. It remains conservatively capitalised at S$2.35bn of equity, and pays half its profits as dividends.
The investment debate is about durability, not quality. History is clear that this company's earnings swing with exchange turnover; it has posted two drawdowns of 30% or more in profit within the past five years. The 1H2026 balance sheet shows the group leaning into the boom: borrowings doubled, receivables surged and credit charges rose sharply. That is rational at the top of a volume cycle, but it raises the cost of a downturn. Meanwhile, the competitive frontier is moving toward digital platforms growing three to five times faster, and governance — a combined Chairman/MD, two MAS penalties and visible insider selling — caps the multiple the market is willing to pay.
At about S$3.52, roughly 11x trailing earnings and 1.5x book, the shares price in some normalisation but not a full reversal. The balance of evidence supports a constructive but cyclical stance: fundamentals and near-term momentum (including likely upside to FY2026 forecasts) favour the bulls, while position sizing should reflect the stock's beta to SGX turnover, its thin liquidity, and the credit risk now embedded in an enlarged lending book. The key signals to watch are monthly SGX turnover, the FY2026 impairment line, and whether the wealth mix continues to rise as volumes eventually cool.
APPENDIX A — DATA GAPS AND DISCREPANCIES
| Item | Issue |
|---|---|
| FY2021 company-reported figures | Revenue excl. S&P figures used and flagged |
| FY2023 net profit | Media summary S$165.6m vs AR2025 PATMI S$170.4m; AR2025 used |
| FY2025 profit growth | +7.0% (profit after tax, per results) vs +6.8% (PATMI, per Chairman's statement); both correct on their own basis |
| Employees | ~3,123 (AR2024) vs ~2,000 (AR2025); possible definitional change |
| Shareholding | UOB 31.8% vs 32.2%; Wee Ee Chao 36.1% (UIP + KIP) vs 36.5% (DBS chart) |
| Revenue definitions | S&P "revenue" differs from company revenue (FY2025: S$722.9m vs S$763.5m) |
| Insider trades | Sourced from Simply Wall St; not cross-checked against SGXNet Form 1/3 filings |
| Director ages and full profiles | 44–47) |
| Subsidiary ownership percentages | — |
| ESG ratings | — |
| Credit ratings | — |
| Pricing / commission schedules | — |
| Share price returns | Approximate; based on derived and aggregator prices |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed / tenure | Background (from AR2025 and DBS Initiation) | FY2025 total remuneration (SGD K) |
|---|---|---|---|---|
Wee Ee Chao | Chairman and Managing Director (executive) | Chairman of Kay Hian Holdings since 1996; MD of Kay Hian & Co since 1981; leads UOBKH since the 2000 merger | BBA, American University. Chairman of Haw Par Corporation; non-executive director of UOL Group; director of Kheng Leong Co. and Wee Investment Group; Chairman of the Singapore Tourism Board 2002–2004; former First VP of REDAS. Member of the Wee family that controls UOB (deemed substantial shareholder of UOB) | 10,233 (4.76% fixed salary, 95.24% variable) |
Tang Wee Loke | Non-executive non-independent director; NRC member | Redesignated non-independent in Oct 2023 | — | 51 (fees) |
Leong Kok Mun, Edmund | Non-executive non-independent director; Audit Committee member | — | — | 69 (fees) |
Tay Wee Jin Michael | Independent director | — | — | 49 (fees) |
Jason Leow Juan Thong | Independent director; NRC Chairman; AC member | — | — | 74 (fees) |
Hui Yat Yan, Henry | Independent director | 2 May 2025 | — | 30 (fees, part-year) |
Chan Lay Hoon | Independent director; Audit Committee Chairman; NRC member | 1 July 2025 | — | 40 (fees, part-year) |
Kuah Boon Wee (former) | Independent director | Resigned 1 Oct 2025 (maximum tenure) | — | 71 |
Andrew Suckling (former) | Independent director | Resigned 1 Oct 2025 (maximum tenure) | — | 64 |
Board of Directors — Wee Ee Chao
| Name | Title | Tenure | Background |
|---|---|---|---|
Wee Ee Chao | Chairman and Managing Director | See above | See above |
Wilhem Lee | Senior Executive Director, Singapore | Since 2019 | Sits on regional and structured credit, corporate finance and capital markets committees, plus Singapore, Hong Kong and Malaysia management committees; 38+ years in securities and investment banking, including APAC head of coverage and head of M&A roles at global banks; BBus (Accountancy), RMIT |
Lim Seng Bee (age 60) | Senior Executive Director, Singapore; Group Executive Committee member | Since 1 Jan 2013 | General management of Singapore operations and North Asia regional business; prior Hong Kong securities management experience; BSc, NYU Stern. Brother-in-law of Wee Ee Chao (Rule 704(11) disclosure) |
Soh Ee Beng | Senior Executive Director, Singapore | Since 2024 | General management and development of private wealth management; BAcc (First Class Honours), NTU |
Karman Hsu | CEO, Hong Kong | Since 2012 | 33+ years in securities; formerly Partner at Cazenove & Co, MD at JP Morgan Cazenove (Head of IB Asia), and Head of Equity Corporate Finance at Standard Chartered (HK); independent non-executive director of Kowloon Development; Economics and Commerce, University of Melbourne; CA/CPA |
Stephanus Turangan | CEO, Indonesia | Since Nov 2022 | 30+ years in Indonesian markets; CEO of Trimegah Sekuritas from 2012; prior roles at Danareksa, Deutsche Bank Jakarta, Mandiri Sekuritas, Bahana, Nomura; Case Western Reserve and Baldwin Wallace |
David Lim Meng Hoe | CEO / MD, Malaysia | Since 2012 | 42+ years in Malaysian stockbroking; BEcon, Monash |
Regional Finance and Operations Director | Finance | — | — |
Directors' Remuneration
| Governance feature | Status | Assessment |
|---|---|---|
Board size | 7 directors | Appropriate for size |
Independence | 4 of 7 independent (57%); 6 of 7 non-executive | Majority independent, meeting the Code |
Chair/CEO separation | Combined — Wee Ee Chao is Chairman and MD | Departure from best practice; no lead independent director appointed (AR2025 explains why) |
Committees | Audit Committee (chaired by an ID); Nominating and Remuneration Committee (merged 1 Oct 2025; chaired by an ID) | No separate risk committee at board level; risk oversight sits with the AC |
Board gender diversity | 1 woman of 7 (14%) | Low versus SGX peers |
Board renewal | Two long-tenured IDs replaced in 2025 | Positive renewal |
Meeting cadence | Board met twice in Jan–Sep 2025; AC met 4 times in FY2025 | Light board cadence |
External board evaluation | None in FY2025 | Self-evaluation only |
Remuneration disclosure | Full for directors; aggregate only for top 5 KMP | Partial compliance with Code Principle 8 (explained) |
Clawback provisions | None (considered "not relevant" for now) | Weakness |
Interested person transactions | Rent from Chairman-linked Peak Properties; rent paid to UOB affiliate; no IPT mandate | Low value; disclosed |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Oct 2023 | Tang Wee Loke redesignated non-executive non-independent | Followed SGX RegCo queries on whether the board and NC had conducted a sufficiently rigorous independence review |
2 May 2025 | Hui Yat Yan, Henry appointed independent director | Board renewal |
1 Jul 2025 | Chan Lay Hoon appointed independent director; later Audit Committee Chair | Board renewal |
1 Oct 2025 | Kuah Boon Wee and Andrew Suckling resign | Reached maximum tenure for independent directors |
1 Oct 2025 | Nominating and Remuneration Committees merged into the NRC | Streamlining |
Major Shareholders
| Holder | Stake (%) | Source / date |
|---|---|---|
United Overseas Bank Limited | 31.8 | DBS Initiation (S&P Cap IQ), July 2026 |
U.I.P. Holdings Ltd (Wee Ee Chao vehicle) | 19.1 | DBS Initiation (S&P Cap IQ) |
K.I.P. Inc (Wee Ee Chao vehicle) | 17.0 | DBS Initiation (S&P Cap IQ) |
Free float | 32.1 | DBS Initiation (S&P Cap IQ) |
Governance Timeline
| Date | Insider | Action | Shares | Approx. value |
|---|---|---|---|---|
2 May 2025 | K.I.P. Inc | Buy | 139,753 | S$0.25m |
10–26 Jun 2025 | Tang Wee Loke | Sell (4 trades) | ~2.46m | ~S$4.8m |
7 Jul 2025 | Wee Ee Chao | Sell | 14,412,437 | ~S$22.4m |
7 Jul 2025 | Tang Wee Loke | Sell | 901,700 | ~S$1.9m |
9 Sep – 6 Nov 2025 | Tang Wee Loke | Sell (8 trades) | ~6.83m | ~S$17.2m |
Competitive Landscape
Competitors by Segment
| Market | Competitor | Type | Notes |
|---|---|---|---|
Singapore | Phillip Securities (PhillipCapital) | Private, independent | DBS channel checks: UOBKH and Phillip together hold close to half of Singapore retail brokerage share; financials not publicly disclosed |
Singapore | DBS Vickers / DBS digital trading | Bank-owned | Part of DBS Group; standalone financials not disclosed |
Singapore | OCBC Securities | Bank-owned | Part of OCBC; standalone financials not disclosed |
Singapore / Malaysia | Maybank Securities | Bank-owned | Part of Maybank |
Singapore / Malaysia | CGS International Securities | Owned by China Galaxy Securities | Regional peer |
Singapore / HK / global | Futu Holdings (moomoo) | Digital-native, Nasdaq-listed | FY2025 revenue HK$22.85bn, net income HK$11.30bn; moomoo ranked first by downloads in Singapore and Malaysia |
Singapore / global | UP Fintech (Tiger Brokers) | Digital-native, Nasdaq-listed | FY2025 revenue US$612.1m, net income US$170.9m; Singapore is its HQ market |
Singapore / global | Interactive Brokers | Digital-native, global | — |
Singapore / HK | iFAST Corporation (FSMOne) | Digital wealth platform, SGX-listed | FY2025 revenue S$514.7m, net profit S$100.0m, AUA S$31.98bn |
Singapore | Saxo Markets, Lim & Tan Securities, KGI Securities | Various | — |
Malaysia | Maybank IB, RHB IB, Hong Leong IB, Kenanga, Public Investment Bank | Bank-owned / independent | — |
Thailand | Bualuang Securities, KGI Thailand, Kasikorn Securities, InnovestX | Bank-owned / independent | — |
Indonesia | Mandiri Sekuritas, BCA Sekuritas, Mirae Asset Sekuritas, Trimegah | Various | — |
Hong Kong | Bright Smart Securities, Phillip HK, BOCI Securities, Futu | Various | Futu claims half of new HK Main Board IPOs and 49% of public IPO subscription value on its platform in 2025 |
Peer Comparison FY2025
| Metric (FY2025) | UOB-Kay Hian | iFAST Corporation | Futu Holdings | UP Fintech (Tiger) |
|---|---|---|---|---|
Listing | SGX | SGX | Nasdaq / HKEX | Nasdaq |
Revenue (local currency) | S$763.5m | S$514.7m | HK$22,846.9m | US$612.1m |
Revenue (approx. SGD Mn, for scale only) | 763 | 515 | ~3,800 | ~790 |
Revenue growth | +13.9% | +34.4% | +68.1% | +56.3% |
Net profit (local currency) | S$239.4m | S$100.0m | HK$11,301.9m | US$170.9m |
Net profit growth | +6.8% | +50.1% | +108.0% | +181.4% |
Net margin (net profit / revenue) | 31.4% | 19.4% | 49.5% | 27.9% |
Client assets | S$5.99bn client trust balances (narrower definition) | AUA S$31.98bn | HK$1.23trn | US$60.8bn |



